Drugging the microbiome and bacterial live biotherapeutic consortium production

Research leading to characterization, quantification, and functional attribution of the microbes throughout the human body has led to many drug-development programs. These programs aim to manipulate a patient’s microbiome through the addition of new strains or functions, the subtraction of deleterio...

Full description

Saved in:
Bibliographic Details
Published inCurrent opinion in biotechnology Vol. 78; p. 102801
Main Authors McChalicher, Christopher WJ, Auniņš, John G
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.12.2022
Subjects
Online AccessGet full text

Cover

Loading…